Benjamin F. Cravatt
Scientific & Clinical Advisory Board MemberDr. Benjamin F. Cravatt, III, Ph.D., also known as Ben, is Director of Alnylam Pharmaceuticals, Inc. from June 1, 2026. Dr. Cravatt is Scientific Advisor of Sirenas Marine Discovery LLC. Dr. Benjamin is Scientific Founders of Architect Therapeutics, Inc. He is Member of Advisory Board of Enveda Therapeutics, Inc. He serves as Director of Actio Biosciences, Inc. since May 2024. He serves as Director at Setara Biosciences, Inc. He serves as Co-Founder of Kisbee Therapeutics, Inc. He was a Director of Sea Pharmaceuticals, LLC. He serves as a Scientific & Clinical Advisory Board Member of Boundless Bio, Inc. He serves as a Member of Scientific Advisory Board at Quanta Therapeutics, Inc and served asMember of Scientific Advisory Board at Biosplice Therapeutics, Inc until 2025. He is Co-Founder of Belharra Therapeutics, Inc. and serves as its Director. Dr. Cravatt is the Founder and Advisor of Magnet Biomedicine. He serves as Member of Scientific Advisory Board of Alterome Therapeutics, Inc. since January 2023. Dr. Cravatt serves as Member of Scientific Advisory Board of Atavistik Bio, Inc. since September 2022. Dr. Cravatt served as Member of Scientific Advisory Board at St. Jude Children's Research Hospital, Inc. until April 2022. Dr. Cravatt is a Co-Founder and serves as Member of Scientific Advisory Board of Kojin Therapeutics, Inc. Dr. Cravatt serves as Director and Member of Scientific Advisor at Autobahn Therapeutics, Inc. He served as Director at FibroGen, Inc. since August 5, 2020 until September 30, 2024. He is Co-Founder of Abide Therapeutics Inc. Dr. Cravatt serves as Scientific Advisor of 5AM Venture Management LLC. Dr. Cravatt serves as Professor of Skaggs Institute for Chemical Biology at The Scripps Research Institute. Dr. Cravatt co-founded ActivX Biosciences Inc. in 2000. He is a Scientific Co-Founder of Vividion Therapeutics, Inc. and serves as its Director since March 2016. He Co-Founded at Boundless Bio, Inc. and served as its Director. He serves as Co-Founder & Member of Scientific Advisory Board of Exo Therapeutics, Inc. and Jnana Therapeutics Inc. He has been a Member of Advisory Board of Tempest Therapeutics Inc. since May 2019. He is a nationally recognized leader in the fields of Bioorganic Chemistry and Enzymology. He serves as Member of Scientific Advisory Board at Turning Pt Therapeutics Inc. since August 2020. His group has obtained fundamental insights into the chemical, biochemical and physiological workings of several important mammalian serine hydrolases, including enzymes involved in the neurobiology of pain and in proteases associated with tumor progression. He served as a Member of Scientific Advisory Board for ActivX Biosciences Inc. and aTyr Pharma Inc. He served as a Member of Pharmaceutical Advisory Committee at Ironwood Pharmaceuticals, Inc. until February 25, 2017. Dr. Cravatt joined the faculty at The Scripps Research Institute in 1997. His honors include a Searle Scholar Award in 2001, the Eli Lilly Award in Biological Chemistry in 2004, a Cope Scholar Award in 2005, the Irving Sigal Young Investigator Award in 2007 and the Tetrahedron Young Investigator Award in Bioorganic and Medicinal Chemistry in 2008, the ASBMB Merck Award, the RSC Jeremy Knowles Award, the AACR Award for Achievement in Chemistry in Cancer Research and memberships in the American Academy of Arts and Sciences, National Academy of Inventors, National Academy of Medicine and National Academy of Sciences. Dr. Cravatt is an Associate Editor for Journal of the American Chemical Society. He is a the Gilula Chair of Chemical Biology and professor in the Department of Chemistry at The Scripps Research Institute. Dr. Cravatt received his B. S. in Biological Sciences and B. A. in History from Stanford University in 1992. He received Ph. D. in Macromolecular, Cellular Structure and Chemistry from The Scripps Research Institute (TSRI) in 1996.
公司職務
- 公司名稱Boundless Bio, Inc.股票代碼BOLD職務Scientific & Clinical Advisory Board Member共事同僚
- JOJessica OienPresident, Principal Executive Officer, Chief Legal Officer & Corporate Secretary
- JEJonathan E. LimCo-Founder & Independent Chairman
- DHDavid HinkleSenior VP of Finance, Controller & Corporate Treasurer
- MWMeredith WesleyChief Human Resources Officer
- JLJennifer LewIndependent Director
- PSPaul S. MischelChairman of Scientific Advisory Board
- JGJames G. ChristensenIndependent Director
